Surgery in microscopically pathological N2 non-small cell lung cancer: the size of lymph node matters

Affiliations

¹ Division of Thoracic Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan;; School of Medicine, National Yang-Ming University, Taipei, Taiwan.

Editorial

Ming-Ching Lee et al. J Thorac Dis. 2017 Feb.

. 2017 Feb;9(2):230-232.

doi: 10.21037/jtd.2017.02.46.

¹ Division of Thoracic Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan;; School of Medicine, National Yang-Ming University, Taipei, Taiwan.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer.
Garelli E, Renaud S, Falcoz PE, Weingertner N, Olland A, Santelmo N, Massard G. Garelli E, et al. Eur J Cardiothorac Surg. 2016 Aug;50(2):322-8. doi: 10.1093/ejcts/ezw036. Epub 2016 Feb 25. Eur J Cardiothorac Surg. 2016. PMID: 26920941

1. Garelli E, Renaud S, Falcoz PE, et al. Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer. Eur J Cardiothorac Surg 2016;50:322-8. 10.1093/ejcts/ezw036 - DOI - PubMed
1. Green MR, Lilenbaum RC. Stage IIIA category of non-small-cell lung cancer: a new proposal. J Natl Cancer Inst 1994;86:586-8. 10.1093/jnci/86.8.586 - DOI - PubMed
1. Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000;18:2981-9. - PubMed
1. Detterbeck F. What to do with "Surprise" N2?: intraoperative management of patients with non-small cell lung cancer. J Thorac Oncol 2008;3:289-302. 10.1097/JTO.0b013e3181630ebd - DOI - PubMed
1. Dooms C, Verbeken E, Stroobants S, et al. Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography. J Clin Oncol 2008;26:1128-34. 10.1200/JCO.2007.13.9550 - DOI - PubMed